Top Markets
Coin of the day
Tien Liang BioTech Co., Ltd. Tien Liang BioTech Co., Ltd.

Tien Liang BioTech Co., Ltd.

4127
Rank in Stocks #20704
Tien Liang BioTech Co., Ltd., established in 1960 and headquartered in New... Tien Liang BioTech Co., Ltd., established in 1960 and headquartered in New Taipei City, Taiwan, is a pharmaceutical enterprise involved in the development, manufacturing, and global distribution of a diverse array of health and medicinal products. The company's offerings include traditional Chinese medicine (TCM) formulations, predominantly in pill form. These remedies address a broad spectrum of conditions, such as internal organ deficiencies (e.g., liver and kidney), various forms of musculoskeletal and neuropathic discomfort (including low back pain, joint pain, rheumatism, gout, and neuralgia), and common ailments like dizziness, digestive issues (constipation, hemorrhoids), respiratory symptoms (colds, bronchitis, coughs), and skin conditions (athlete's foot). Additionally, Tien Liang BioTech provides a range of Western pharmaceutical products. This segment features topical applications like ointments, pain relief gels, soreness sprays, and transdermal pain patches, alongside oral preparations such as tablets and capsules. The portfolio also includes specialized items like hair removal creams. Beyond pharmaceuticals, the company extends its reach into general consumer health and personal care. These offerings comprise products designed for body relaxation and comfort, items to alleviate post-exercise discomfort, oral hygiene products, and various soaps.
Share Price
$2.71
Market Cap
$124.12M
Change (1 day)
-3.62%
Change (1 year)
138.18%
Country
TW
Trade Tien Liang BioTech Co., Ltd. (4127)

Category

P/B ratio for Tien Liang BioTech Co., Ltd. (4127)
P/B ratio as of 2026 TTM: 0
According to Tien Liang BioTech Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Tien Liang BioTech Co., Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors